SCHEMBL18878298

SCHEMBL18878298

CC1(C)c2ccccc2-c2cccc(-c3cc(-c4nc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccc(-c6ccccc6)cc5)n4)cc(-c4cccc5c4C(C)(C)c4ccccc4-5)c3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
PDK2 Q15119 5/20 0.35
RARB P10826 2/20 0.35
RARG P13631 2/20 0.35
RARA P10276 1/20 0.35
NTSR1 P30989 1/20 0.34
ADORA2A P29274 3/20 0.34
ADORA1 P30542 3/20 0.34
ADORA3 P0DMS8 2/20 0.34
ADORA2B P29275 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18878296 1.00 L3MBTL1 (0.39) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18878295 0.94 L3MBTL1 (0.39) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18878290 0.94 L3MBTL1 (0.39) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL29312000 0.93 PDK2 (0.36) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17887187 0.93 PDK2 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17151623 0.93 PDK2 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL26937562 0.93 PDK2 (0.38) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17151618 0.93 L3MBTL1 (0.42) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18878277 0.93 L3MBTL1 (0.42) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL17151707 0.93 L3MBTL1 (0.42) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210074925-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-11 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 L3MBTL1 4418/4885MEN1 3213/4885KMT2A 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.